Literature DB >> 3713111

Sideroachrestic anemia with iron loading: treatment with desferrioxamine.

W G Zoller, R Hehlmann.   

Abstract

A case of nontransfusion-dependent sideroachrestic anemia (SA) with hemosiderosis is described that showed significant improvement of hemosiderosis and fibrosis of the liver following treatment with desferrioxamine. The anemia, although not transfusion dependent, did not allow continued therapy with phlebotomies. Following the removal of about 16 g iron over 4.5 years, normalization of serum ferritin and reversal of fibrosis of the liver were observed. Management problems and the prognostic implications of desferrioxamine therapy are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3713111     DOI: 10.1007/bf01727527

Source DB:  PubMed          Journal:  Klin Wochenschr        ISSN: 0023-2173


  29 in total

1.  SIDEROBLASTIC ANAEMIA, MITOCHONDRIA AND ERYTHROBLASTIC IRON.

Authors:  M C BESSIS; W N JENSEN
Journal:  Br J Haematol       Date:  1965-01       Impact factor: 6.998

2.  SIDEROBLASTIC ANAEMIA IN MAN: OBSERVATIONS ON SEVENTY CASES.

Authors:  B H MACGIBBON; D L MOLLIN
Journal:  Br J Haematol       Date:  1965-01       Impact factor: 6.998

3.  Determination of chelated iron in the urine.

Authors:  M Barry
Journal:  J Clin Pathol       Date:  1968-03       Impact factor: 3.411

4.  Subcutaneous infusion and intramuscular injection of desferrioxamine in patients with transfusional iron overload.

Authors:  M A Hussain; N Green; D M Flynn; S Hussein; A V Hoffbrand
Journal:  Lancet       Date:  1976-12-11       Impact factor: 79.321

Review 5.  Iron overload.

Authors:  J W Halliday; L W Powell
Journal:  Semin Hematol       Date:  1982-01       Impact factor: 3.851

6.  Iron overload in cardiac valvular disease and pure red cell aplasia: treatment with desferrioxamine.

Authors:  R Hehlmann; H Schmitz; K Krüger
Journal:  Int J Cardiol       Date:  1984-06       Impact factor: 4.164

7.  Reassessment of the use of desferrioxamine B in iron overload.

Authors:  R D Propper; S B Shurin; D G Nathan
Journal:  N Engl J Med       Date:  1976-06-24       Impact factor: 91.245

Review 8.  Idiopathic refractory sideroblastic anemia: incidence and risk factors for leukemic transformation.

Authors:  D S Cheng; J P Kushner; M M Wintrobe
Journal:  Cancer       Date:  1979-08       Impact factor: 6.860

9.  Intravenous and subcutaneous desferrioxamine therapy in children with severe iron overload.

Authors:  G E Janka; P Möhring; M Helmig; R J Haas; K Betke
Journal:  Eur J Pediatr       Date:  1981-11       Impact factor: 3.183

10.  Effect of dose, time, and ascorbate on iron excretion after subcutaneous desferrioxamine.

Authors:  M A Hussain; N Green; D M Flynn; A V Hoffbrand
Journal:  Lancet       Date:  1977-05-07       Impact factor: 79.321

View more
  1 in total

1.  Erythrocytapheresis. A method for rapid extracorporeal elimination of erythrocytes. Results in 65 patients.

Authors:  W G Zoller; H Kellner; F A Spengel
Journal:  Klin Wochenschr       Date:  1988-05-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.